Baseline Characteristics of Patients With Severe Asthma Treated With Mepolizumab: An Interim Analysis of a Multi-country Real-world Cohort

被引:0
|
作者
Allehebi, R. O. [1 ]
Maturu, V. Nagarjuna [2 ]
Mahboub, B. [3 ]
Bavbek, S. [4 ]
Fernandez, P. [5 ]
Rosales, D. Cano [6 ]
Soares, C. [7 ]
Abreu, G. [7 ]
Valladares, R. [7 ]
Queiroz, J. [7 ]
Menezes, P. [7 ]
Raimondi, A. [8 ]
Aziz, F. [9 ]
Pizzichini, E. [7 ]
Laucho-Contreras, M. [10 ]
Noibi, S. [11 ]
机构
[1] King Fahad Med City, Riyadh, Saudi Arabia
[2] Yashoda Super Special Hosp, Hyderabad, India
[3] Rashid Hosp, Dubai Hlth Author, Dubai, U Arab Emirates
[4] Ankara Univ, Sch Med, Ankara, Turkiye
[5] Chilean Natl Inst, Santiago, Chile
[6] Inst Neumol Oriente, Asthma Clin, Santander, Colombia
[7] GSK, Rio De Janeiro, Brazil
[8] GSK, Buenos Aires, DF, Argentina
[9] GSK, Dubai, U Arab Emirates
[10] GSK, Bogota, Colombia
[11] GSK, Jeddah, U Arab Emirates
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1313
引用
收藏
页数:3
相关论文
共 50 条
  • [41] International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Sanchez, Carlos Almonacid
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Maxwell, Aoife
    Price, Robert
    Howarth, Peter
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [42] Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland
    Koistinen, Ville
    Kauppi, Paula
    Idanpaan-Heikkila, Juhana
    Veijalainen, Lauri
    Iso-Mustajarvi, Ilona
    Ylisaukko-Oja, Tero
    Mehtala, Juha
    Viinanen, Arja
    Kilpelainen, Maritta
    JOURNAL OF ASTHMA, 2022, 59 (12) : 2375 - 2385
  • [43] Real-World mepolizumab outcomes in severe asthma; REALITI- A post hoc analysis by exacerbation history
    Bagnasco, D.
    Lougheed, D.
    Subramanian, V
    Clifton, I
    Price, R.
    Howarth, P.
    Skowasch, D.
    PNEUMOLOGIE, 2024, 78 : S10 - S11
  • [44] Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
    Portacci, Andrea
    Campisi, Raffaele
    Buonamico, Enrico
    Nolasco, Santi
    Pelaia, Corrado
    Crimi, Nunzio
    Benfante, Alida
    Triggiani, Massimo
    Spadaro, Giuseppe
    Caiaffa, Maria Filomena
    Scioscia, Giulia
    Detoraki, Aikaterini
    Valenti, Giuseppe
    Papia, Francesco
    Tomasello, Alessandra
    Scichilone, Nicola
    Pelaia, Girolamo
    Crimi, Claudia
    Carpagnano, Giovanna Elisiana
    ERJ OPEN RESEARCH, 2023, 9 (05)
  • [45] Real-world mepolizumab outcomes in severe asthma: REALITI-A post hoc analysis by exacerbation history
    Bagnasco, Diego
    Lougheed, Diane
    Subramanian, Vijay
    Clifton, Ian J.
    Price, Robert G.
    Howarth, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [46] Baseline characteristics of the first real-world atopic dermatitis patients on Dupilumab in Germany - interim analysis of the PROLEAD study
    Riebel, S.
    Augustin, M.
    Bley, O.
    Schmitt, J.
    Sebastian, M.
    Zaun, S.
    Thaci, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 190 - 190
  • [47] BASELINE CHARACTERISTICS OF DIABETIC MACULAR EDEMA PATIENTS FROM THE SECOND INTERIM ANALYSIS OF THE REAL-WORLD LUMINOUS STUDY
    Minnella, A. M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (03) : E24 - E24
  • [48] C3 GLOMERULOPATHY CURRENT THERAPY AND REAL-WORLD MANAGEMENT - INTERIM RESULTS FROM A MULTI-COUNTRY STUDY
    Proudfoot, Clare
    Pannagl, Katharina
    Ndife, Briana
    King, Andrea
    Murphy, Kathleen
    Libby, Susanna
    Lafayette, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I675 - I675
  • [49] Mepolizumab for Treatment of Severe Eosinophilic Asthma: A 5-Year Real-World Experience
    Loli-Ausejo, D.
    Perdomo, G.
    Mascaro, B.
    Martinez-Olondris, P.
    Sanchez-Fernandez, M. C.
    Mullol, J.
    Valero, A.
    Arismendi, E.
    Bobolea, I
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (03) : 209 - 210
  • [50] Real-world experience of mepolizumab in severe eosinophilic asthma - five-year outcomes
    Nuttall, Amy
    Fyles, Fred
    Joplin, Hannah
    Burhan, Hassan
    Watkins, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62